Figure 3 | British Journal of Cancer

Figure 3

From: Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy

Figure 3

Reduction of PET dimensions and of SUVmax after one cycle of Trastuzumab therapy is shown in A, B and C, respectively. Linear regression analysis of reduction of clinical dimensions vs PET dimension reduction, SUVmax reduction and reduction of HF1α-positive cells after trastuzmab is shown in DF) respectively. Group analysis according to HIF1α status (low vs high) of percentage reduction of PET dimensions is shown in Figure 1G. Group analysis according to HER2 status (low vs high) of percentage reduction of SUVmax is shown in (H). Bars show standard errors and midline the mean value.

Back to article page